 Kristen DeSanto
Concepts (261)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myofascial Pain Syndromes | 2 | 2023 | 12 | 1.620 |
Why?
| | Acupuncture Therapy | 2 | 2023 | 21 | 1.610 |
Why?
| | Low Back Pain | 2 | 2023 | 108 | 1.440 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 2 | 2022 | 350 | 1.090 |
Why?
| | Patient Education as Topic | 2 | 2022 | 766 | 0.920 |
Why?
| | Sleep-Wake Transition Disorders | 1 | 2023 | 4 | 0.860 |
Why?
| | Nutrition Therapy | 1 | 2023 | 37 | 0.830 |
Why?
| | Fibromyalgia | 1 | 2023 | 52 | 0.810 |
Why?
| | Naltrexone | 1 | 2023 | 97 | 0.770 |
Why?
| | Postmenopause | 1 | 2023 | 366 | 0.700 |
Why?
| | Water Sports | 1 | 2020 | 3 | 0.690 |
Why?
| | Hallucinogens | 1 | 2022 | 105 | 0.670 |
Why?
| | Antipsychotic Agents | 1 | 2022 | 194 | 0.660 |
Why?
| | Analgesics | 2 | 2022 | 206 | 0.660 |
Why?
| | Ganglion Cysts | 1 | 2020 | 9 | 0.650 |
Why?
| | Wound Healing | 1 | 2022 | 331 | 0.640 |
Why?
| | Behavior Therapy | 1 | 2022 | 264 | 0.630 |
Why?
| | Carcinoma, Basal Cell | 1 | 2020 | 75 | 0.630 |
Why?
| | Anti-Asthmatic Agents | 1 | 2023 | 395 | 0.630 |
Why?
| | Wrist | 1 | 2020 | 54 | 0.620 |
Why?
| | Spironolactone | 1 | 2019 | 36 | 0.610 |
Why?
| | Diuretics | 1 | 2019 | 74 | 0.610 |
Why?
| | Memory | 1 | 2021 | 248 | 0.600 |
Why?
| | Clostridium Infections | 1 | 2019 | 73 | 0.570 |
Why?
| | Communication | 3 | 2021 | 879 | 0.570 |
Why?
| | Glycemic Index | 1 | 2018 | 27 | 0.570 |
Why?
| | Viscosupplements | 1 | 2018 | 11 | 0.570 |
Why?
| | Proton Pump Inhibitors | 1 | 2019 | 109 | 0.570 |
Why?
| | Pneumonia, Bacterial | 1 | 2019 | 116 | 0.560 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 383 | 0.560 |
Why?
| | Musculoskeletal System | 1 | 2018 | 48 | 0.550 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2022 | 2531 | 0.550 |
Why?
| | Testosterone | 1 | 2021 | 409 | 0.520 |
Why?
| | Community-Acquired Infections | 1 | 2019 | 174 | 0.520 |
Why?
| | Humans | 50 | 2024 | 137585 | 0.520 |
Why?
| | Gastroesophageal Reflux | 1 | 2019 | 234 | 0.510 |
Why?
| | Randomized Controlled Trials as Topic | 5 | 2024 | 1477 | 0.500 |
Why?
| | Chagas Disease | 3 | 2021 | 44 | 0.490 |
Why?
| | Sleep | 1 | 2022 | 755 | 0.490 |
Why?
| | Hyaluronic Acid | 1 | 2018 | 225 | 0.480 |
Why?
| | Cannabis | 1 | 2022 | 494 | 0.470 |
Why?
| | Pain Measurement | 3 | 2023 | 521 | 0.460 |
Why?
| | Osteoarthritis, Knee | 1 | 2018 | 254 | 0.450 |
Why?
| | Athletic Injuries | 1 | 2020 | 529 | 0.420 |
Why?
| | Glucocorticoids | 1 | 2018 | 594 | 0.410 |
Why?
| | Skin Neoplasms | 1 | 2020 | 855 | 0.400 |
Why?
| | Upper Extremity | 2 | 2024 | 99 | 0.360 |
Why?
| | Health Promotion | 1 | 2018 | 741 | 0.360 |
Why?
| | Hormone Replacement Therapy | 2 | 2023 | 100 | 0.350 |
Why?
| | Palliative Care | 4 | 2024 | 758 | 0.350 |
Why?
| | Asthma | 1 | 2023 | 2295 | 0.330 |
Why?
| | Hypertension | 1 | 2019 | 1295 | 0.320 |
Why?
| | Pain Management | 2 | 2023 | 352 | 0.270 |
Why?
| | Cardiomyopathies | 2 | 2021 | 350 | 0.270 |
Why?
| | Advance Care Planning | 2 | 2021 | 209 | 0.260 |
Why?
| | Cardiovascular Diseases | 1 | 2019 | 2111 | 0.260 |
Why?
| | Ovarian Neoplasms | 2 | 2024 | 565 | 0.250 |
Why?
| | Sepsis | 2 | 2022 | 617 | 0.240 |
Why?
| | Peripheral Nerve Injuries | 1 | 2024 | 36 | 0.220 |
Why?
| | Parental Leave | 1 | 2024 | 26 | 0.220 |
Why?
| | Egg Hypersensitivity | 1 | 2024 | 27 | 0.220 |
Why?
| | Milk Hypersensitivity | 1 | 2024 | 19 | 0.220 |
Why?
| | Population Groups | 2 | 2021 | 62 | 0.220 |
Why?
| | Muscle Cramp | 1 | 2023 | 7 | 0.220 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2024 | 50 | 0.220 |
Why?
| | Live Birth | 1 | 2024 | 66 | 0.210 |
Why?
| | Psychosocial Support Systems | 1 | 2023 | 12 | 0.210 |
Why?
| | Amitriptyline | 1 | 2023 | 21 | 0.210 |
Why?
| | Preconception Care | 1 | 2024 | 43 | 0.210 |
Why?
| | Trigger Points | 1 | 2023 | 13 | 0.210 |
Why?
| | Desensitization, Immunologic | 1 | 2024 | 96 | 0.200 |
Why?
| | Magnesium | 1 | 2023 | 156 | 0.200 |
Why?
| | Urogenital Abnormalities | 1 | 2023 | 64 | 0.200 |
Why?
| | Stroke | 2 | 2022 | 1120 | 0.200 |
Why?
| | Fertility | 1 | 2024 | 160 | 0.200 |
Why?
| | Quetiapine Fumarate | 1 | 2022 | 23 | 0.200 |
Why?
| | Aripiprazole | 1 | 2022 | 20 | 0.190 |
Why?
| | Job Satisfaction | 1 | 2024 | 218 | 0.190 |
Why?
| | Transition to Adult Care | 1 | 2023 | 91 | 0.190 |
Why?
| | Rectum | 1 | 2023 | 185 | 0.190 |
Why?
| | Leg | 1 | 2023 | 236 | 0.190 |
Why?
| | Administration, Inhalation | 1 | 2023 | 688 | 0.180 |
Why?
| | Chagas Cardiomyopathy | 1 | 2021 | 24 | 0.180 |
Why?
| | Practice Guidelines as Topic | 2 | 2020 | 1587 | 0.180 |
Why?
| | Insulin, Isophane | 1 | 2021 | 21 | 0.180 |
Why?
| | Wounds, Gunshot | 1 | 2024 | 228 | 0.180 |
Why?
| | Colon | 1 | 2023 | 282 | 0.180 |
Why?
| | Benzodiazepines | 1 | 2022 | 155 | 0.180 |
Why?
| | Aged, 80 and over | 5 | 2021 | 7635 | 0.180 |
Why?
| | Back Injuries | 1 | 2020 | 5 | 0.170 |
Why?
| | Dermoscopy | 1 | 2020 | 10 | 0.170 |
Why?
| | Drowning | 1 | 2020 | 6 | 0.170 |
Why?
| | Insulin Glargine | 1 | 2021 | 84 | 0.170 |
Why?
| | Drug Therapy, Combination | 1 | 2023 | 1066 | 0.170 |
Why?
| | Facial Injuries | 1 | 2020 | 21 | 0.170 |
Why?
| | Neck Injuries | 1 | 2020 | 21 | 0.170 |
Why?
| | Torso | 1 | 2020 | 33 | 0.170 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2022 | 1242 | 0.170 |
Why?
| | Attitude to Computers | 1 | 2020 | 29 | 0.170 |
Why?
| | Health Information Exchange | 1 | 2020 | 23 | 0.160 |
Why?
| | Education, Medical, Graduate | 1 | 2024 | 486 | 0.160 |
Why?
| | Ambulances | 1 | 2020 | 51 | 0.160 |
Why?
| | Patient Selection | 1 | 2024 | 696 | 0.160 |
Why?
| | Transgender Persons | 1 | 2023 | 186 | 0.160 |
Why?
| | Bone and Bones | 1 | 2022 | 317 | 0.160 |
Why?
| | Adrenal Cortex Hormones | 1 | 2023 | 565 | 0.160 |
Why?
| | Pelvis | 1 | 2020 | 102 | 0.160 |
Why?
| | Nurse's Role | 1 | 2021 | 161 | 0.160 |
Why?
| | Intrauterine Devices | 1 | 2019 | 31 | 0.160 |
Why?
| | Sexual and Gender Minorities | 1 | 2023 | 214 | 0.160 |
Why?
| | Dietary Supplements | 1 | 2023 | 561 | 0.160 |
Why?
| | Wearable Electronic Devices | 1 | 2020 | 53 | 0.150 |
Why?
| | Teaching | 1 | 2021 | 224 | 0.150 |
Why?
| | Shock, Septic | 1 | 2021 | 219 | 0.150 |
Why?
| | Patient Readmission | 1 | 2024 | 697 | 0.150 |
Why?
| | Colonoscopy | 1 | 2021 | 245 | 0.150 |
Why?
| | Craniocerebral Trauma | 1 | 2020 | 170 | 0.150 |
Why?
| | Volunteers | 1 | 2018 | 29 | 0.150 |
Why?
| | Long-Term Care | 1 | 2019 | 107 | 0.140 |
Why?
| | Weight Loss | 1 | 2024 | 787 | 0.140 |
Why?
| | Radiography, Thoracic | 1 | 2019 | 167 | 0.140 |
Why?
| | Injections, Intra-Articular | 1 | 2018 | 49 | 0.140 |
Why?
| | Visual Analog Scale | 1 | 2018 | 33 | 0.140 |
Why?
| | Pain | 1 | 2023 | 756 | 0.140 |
Why?
| | Burnout, Professional | 1 | 2024 | 442 | 0.140 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2019 | 157 | 0.140 |
Why?
| | Terminal Care | 1 | 2021 | 232 | 0.140 |
Why?
| | Female | 13 | 2024 | 73304 | 0.140 |
Why?
| | Cytokines | 2 | 2022 | 2085 | 0.140 |
Why?
| | Cooperative Behavior | 1 | 2020 | 451 | 0.130 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 786 | 0.130 |
Why?
| | Library Services | 1 | 2016 | 8 | 0.130 |
Why?
| | Libraries, Medical | 1 | 2016 | 11 | 0.130 |
Why?
| | Cryptococcus | 1 | 2016 | 11 | 0.130 |
Why?
| | Antigens, Fungal | 1 | 2016 | 28 | 0.130 |
Why?
| | Recurrence | 1 | 2020 | 1060 | 0.130 |
Why?
| | Lower Extremity | 1 | 2020 | 427 | 0.130 |
Why?
| | Hypoglycemia | 1 | 2021 | 445 | 0.130 |
Why?
| | Early Detection of Cancer | 1 | 2021 | 447 | 0.130 |
Why?
| | Meningitis, Cryptococcal | 1 | 2016 | 30 | 0.130 |
Why?
| | Vomiting | 1 | 2016 | 130 | 0.120 |
Why?
| | Hospice Care | 1 | 2019 | 202 | 0.120 |
Why?
| | Emergency Medical Services | 1 | 2022 | 552 | 0.120 |
Why?
| | Survival Analysis | 1 | 2019 | 1325 | 0.120 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 1040 | 0.120 |
Why?
| | Prevalence | 2 | 2021 | 2734 | 0.120 |
Why?
| | Skin | 1 | 2020 | 752 | 0.120 |
Why?
| | Perception | 1 | 2018 | 359 | 0.120 |
Why?
| | Administration, Oral | 1 | 2018 | 816 | 0.120 |
Why?
| | Aged | 6 | 2024 | 23961 | 0.120 |
Why?
| | Ultrasonography | 1 | 2019 | 759 | 0.110 |
Why?
| | Acute Disease | 1 | 2018 | 1007 | 0.110 |
Why?
| | Evidence-Based Medicine | 1 | 2019 | 740 | 0.110 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 2057 | 0.110 |
Why?
| | Risk Factors | 4 | 2024 | 10388 | 0.110 |
Why?
| | Prognosis | 2 | 2022 | 4030 | 0.110 |
Why?
| | Internship and Residency | 1 | 2024 | 1147 | 0.110 |
Why?
| | United States | 5 | 2024 | 14841 | 0.110 |
Why?
| | Cost-Benefit Analysis | 1 | 2016 | 591 | 0.100 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 806 | 0.100 |
Why?
| | Critical Illness | 1 | 2019 | 811 | 0.100 |
Why?
| | Risk Assessment | 2 | 2021 | 3457 | 0.100 |
Why?
| | Depression | 1 | 2022 | 1397 | 0.100 |
Why?
| | Diabetes Mellitus | 1 | 2021 | 1040 | 0.100 |
Why?
| | Wounds and Injuries | 1 | 2019 | 758 | 0.100 |
Why?
| | Blood Glucose | 1 | 2022 | 2186 | 0.090 |
Why?
| | Adult | 8 | 2024 | 37929 | 0.090 |
Why?
| | Emergency Service, Hospital | 1 | 2022 | 2069 | 0.090 |
Why?
| | Male | 9 | 2023 | 67762 | 0.080 |
Why?
| | Child | 4 | 2024 | 21935 | 0.080 |
Why?
| | Middle Aged | 6 | 2024 | 33479 | 0.080 |
Why?
| | Infant | 1 | 2022 | 9465 | 0.070 |
Why?
| | Treatment Outcome | 4 | 2024 | 10811 | 0.070 |
Why?
| | Lung | 1 | 2019 | 4060 | 0.060 |
Why?
| | Heart Failure | 1 | 2019 | 2236 | 0.060 |
Why?
| | Predictive Value of Tests | 2 | 2021 | 2031 | 0.060 |
Why?
| | Eggs | 1 | 2024 | 25 | 0.060 |
Why?
| | Organizational Policy | 1 | 2024 | 84 | 0.050 |
Why?
| | Cooking | 1 | 2024 | 62 | 0.050 |
Why?
| | Research Design | 2 | 2021 | 1139 | 0.050 |
Why?
| | Pregnancy Rate | 1 | 2024 | 65 | 0.050 |
Why?
| | Milk | 1 | 2024 | 124 | 0.050 |
Why?
| | Incidence | 2 | 2021 | 2804 | 0.050 |
Why?
| | Abortion, Spontaneous | 1 | 2024 | 105 | 0.050 |
Why?
| | Infertility, Female | 1 | 2024 | 108 | 0.050 |
Why?
| | Qualitative Research | 2 | 2021 | 1386 | 0.050 |
Why?
| | Gender Identity | 1 | 2023 | 124 | 0.050 |
Why?
| | Immune Tolerance | 1 | 2024 | 363 | 0.050 |
Why?
| | Healthy Volunteers | 1 | 2022 | 199 | 0.050 |
Why?
| | Allergens | 1 | 2024 | 409 | 0.040 |
Why?
| | Meta-Analysis as Topic | 1 | 2021 | 186 | 0.040 |
Why?
| | Technology | 1 | 2021 | 96 | 0.040 |
Why?
| | Tissue Plasminogen Activator | 1 | 2022 | 224 | 0.040 |
Why?
| | Uncertainty | 1 | 2021 | 128 | 0.040 |
Why?
| | Canada | 1 | 2021 | 418 | 0.040 |
Why?
| | Late Onset Disorders | 1 | 2019 | 2 | 0.040 |
Why?
| | Vulnerable Populations | 1 | 2021 | 163 | 0.040 |
Why?
| | Triage | 1 | 2022 | 222 | 0.040 |
Why?
| | Age of Onset | 1 | 2021 | 518 | 0.040 |
Why?
| | Trauma Centers | 1 | 2022 | 421 | 0.040 |
Why?
| | Patient Participation | 1 | 2023 | 420 | 0.040 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2024 | 801 | 0.040 |
Why?
| | Observational Studies as Topic | 1 | 2019 | 117 | 0.040 |
Why?
| | Sexual Behavior | 1 | 2023 | 485 | 0.040 |
Why?
| | Adolescent | 3 | 2023 | 21513 | 0.040 |
Why?
| | Stroke Volume | 1 | 2021 | 612 | 0.040 |
Why?
| | Ventricular Function, Left | 1 | 2021 | 534 | 0.040 |
Why?
| | Health Education | 1 | 2021 | 341 | 0.040 |
Why?
| | Arrhythmias, Cardiac | 1 | 2020 | 333 | 0.030 |
Why?
| | Point-of-Care Systems | 1 | 2019 | 167 | 0.030 |
Why?
| | Health Information Management | 1 | 2016 | 7 | 0.030 |
Why?
| | Electrocardiography | 1 | 2019 | 629 | 0.030 |
Why?
| | Lepidoptera | 1 | 1975 | 8 | 0.030 |
Why?
| | Hospitals, University | 1 | 2016 | 182 | 0.030 |
Why?
| | Aminopeptidases | 1 | 1975 | 18 | 0.030 |
Why?
| | Syndrome | 1 | 2016 | 358 | 0.030 |
Why?
| | Kidney | 1 | 2023 | 1468 | 0.030 |
Why?
| | Moths | 1 | 1975 | 45 | 0.030 |
Why?
| | Chronic Disease | 1 | 2021 | 1793 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2016 | 202 | 0.030 |
Why?
| | Health Personnel | 1 | 2021 | 710 | 0.030 |
Why?
| | Marijuana Abuse | 1 | 2016 | 233 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2023 | 15657 | 0.030 |
Why?
| | Young Adult | 2 | 2023 | 13209 | 0.030 |
Why?
| | Animals | 4 | 2024 | 36940 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2016 | 1483 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2844 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2837 | 0.020 |
Why?
| | Pregnancy | 1 | 2024 | 6763 | 0.020 |
Why?
| | Obesity | 1 | 2024 | 2992 | 0.020 |
Why?
| | Biomedical Research | 1 | 2016 | 692 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3556 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 5778 | 0.020 |
Why?
| | Nucleic Acid Denaturation | 1 | 1976 | 32 | 0.020 |
Why?
| | Colorado | 1 | 2016 | 4565 | 0.020 |
Why?
| | Digitoxin | 1 | 1975 | 4 | 0.020 |
Why?
| | Sulfates | 1 | 1976 | 50 | 0.020 |
Why?
| | Microsomes, Liver | 1 | 1975 | 86 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 2 | 1976 | 560 | 0.010 |
Why?
| | DNA | 1 | 1976 | 1459 | 0.010 |
Why?
| | Mercury | 1 | 1975 | 41 | 0.010 |
Why?
| | Molecular Weight | 1 | 1975 | 335 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1975 | 345 | 0.010 |
Why?
| | Copper | 1 | 1975 | 104 | 0.010 |
Why?
| | Larva | 1 | 1975 | 226 | 0.010 |
Why?
| | Oligopeptides | 1 | 1975 | 271 | 0.010 |
Why?
| | Zinc | 1 | 1975 | 297 | 0.010 |
Why?
| | Kinetics | 1 | 1975 | 1670 | 0.010 |
Why?
| | Amino Acids | 1 | 1975 | 497 | 0.010 |
Why?
| | Chemistry | 1 | 1976 | 45 | 0.000 |
Why?
| | Chemical Phenomena | 1 | 1976 | 83 | 0.000 |
Why?
| | Digitoxigenin | 1 | 1975 | 2 | 0.000 |
Why?
| | Chromatography, Thin Layer | 1 | 1975 | 26 | 0.000 |
Why?
| | Hydroxylation | 1 | 1975 | 39 | 0.000 |
Why?
| | NADP | 1 | 1975 | 49 | 0.000 |
Why?
| | Solutions | 1 | 1976 | 168 | 0.000 |
Why?
| | Thymus Gland | 1 | 1976 | 312 | 0.000 |
Why?
| | In Vitro Techniques | 1 | 1975 | 1092 | 0.000 |
Why?
| | Cattle | 1 | 1976 | 984 | 0.000 |
Why?
| | Rats | 1 | 1975 | 5647 | 0.000 |
Why?
| | Time Factors | 1 | 1975 | 6828 | 0.000 |
Why?
|
|
DeSanto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|